« Back
Home /
Rafoxanide

Rafoxanide

Item no.	TMO-T7093-500mg
Manufacturer	TargetMol
CASRN	22662-39-1
Amount	500 mg
Quantity options	1 mL x 10 mM (in DMSO) 1 g 1 mL 200 mg 2 g 500 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	100.00%
Citations	Xiao W , Xu Z , Chang S , et al. Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway[J]. Cancer Letters, 2019, 444:45-59.
Smiles	C(NC1=CC(Cl)=C(OC2=CC=C(Cl)C=C2)C=C1)(=O)C3=C(O)C(I)=CC(I)=C3
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	22662-39-1,CDK
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Parasite\|\|\|CDK
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	626.01
Description	Rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancer. Rafoxanide is a salicylanilide used as an anthelmintic. It is used to treat fluke, hookworm and other infestations.
Pathways	Microbiology/Virology\|\|\|Cell Cycle/Checkpoint

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 500 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question